Thus, if cimetidine is effective in reducing cutaneous photosensitivity and/or PPIX concentrations in EPP patients, its mechanism of action likely is not via ALAS inhibition. This evidence concerns the gene ALAS1 and autosomal erythropoietic protoporphyria.